Following the birth of her second child in 2023, then-27-year-old Lauren Toole noticed rectal bleeding during bathroom visits. Medical staff prescribed topical creams and discussed treatments for irritable bowel syndrome while her symptoms progressed to include blood clots, alternating constipation, and loose stools.
Three Years of Dismissal After Childbirth
A Rare Neuroendocrine Tumor and Precancerous Polyps
British mother Lauren Toole was diagnosed with a rare neuroendocrine tumor and precancerous polyps after experiencing rectal bleeding and bowel changes following the birth of her second son. According to her public accounts, medical professionals repeatedly attributed her symptoms to postpartum hemorrhoids and irritable bowel syndrome across eight consultations over three years, before an emergency hospital admission for suspected appendicitis led to a diagnostic colonoscopy.
Dismissed Concerns and Antidepressant Prescriptions
During the multi-year diagnostic delay, Toole’s persistent concerns regarding her physical decline were misattributed by some practitioners to health-related anxiety, leading to a prescription for antidepressants. Toole later stated that her anxiety stemmed directly from experiencing severe physical symptoms without adequate medical investigation.
Emergency Admission Triggers Colonoscopy
The diagnostic trajectory shifted when Toole was admitted to a hospital as an emergency case due to suspected appendicitis. During this acute care admission, physicians performed a diagnostic colonoscopy that identified abnormal growths on her colon wall.
Surgical Intervention and Public Advocacy
Laboratory biopsy results confirmed the presence of tubulovillous adenoma, which consists of precancerous cells, alongside a neuroendocrine tumor. Neuroendocrine tumors are a rare form of cancer originating in the body’s hormone-producing and digestive cells. Medical evaluation indicated that if left unaddressed, the precancerous polyps could have developed into a secondary, distinct form of cancer alongside the existing neuroendocrine tumor.
Following the discovery, Toole faced surgical interventions to remove malignant tissue and manage her ongoing recovery. She has since spoken publicly about the psychological toll of diagnostic delay and the importance of advocating for specialized gastrointestinal examinations when initial treatments fail to resolve persistent symptoms.
Keep reading